Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer

被引:50
作者
Davison, B. Joyce [1 ]
Goldenberg, S. Larry [2 ]
机构
[1] Univ Saskatchewan, Coll Nursing, St Andrews Coll, Saskatoon, SK S7N 0W3, Canada
[2] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada
关键词
prostate cancer; active surveillance; decision-making; information preferences; psychological distress; QUALITY-OF-LIFE; TREATMENT DECISIONS; MEN; CARCINOMA; BRACHYTHERAPY; MANAGEMENT; PREFERENCES; PARTNERS; ANTIGEN; CAPSURE;
D O I
10.1111/j.1464-410X.2011.10200.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
100201 [内科学]; 100221 [泌尿外科学];
摘要
OBJECTIVES To examine the decision-making processes of men on active surveillance (AS). To identify the resources that men want to access to make, support and sustain them while on AS. PATIENTS AND METHODS Three-part survey developed for this study based on a qualitative study of 25 men on AS. Survey items explored: role men assumed with their physician in treatment decision-making, factors influencing decision to go on AS, and resources required while on AS. Surveys mailed out to cross-sectional sample of men on AS for less than 10 years. RESULTS 27% of the 73 men reported assuming an active role in treatment decision-making with their urologist, 41% a shared role and 32% a passive role. 82% of men reported being comfortable and 90% being satisfied with their decision to be on AS. 55% reported not being anxious about the cancer progressing while on AS. Urologist's opinion, current age, and impact of treatment on urinary function were main factors influencing treatment decision. Information on future treatment options, non-traditional treatments and diet considered most important resources. CONCLUSIONS Results suggest that once men make a decision to go on AS, they are satisfied with their decision and few report being anxious about progression of cancer. Men are strongly influenced by the treating specialist in taking up AS. Additional information and psychological support resources are required for men on AS.
引用
收藏
页码:1787 / 1793
页数:7
相关论文
共 32 条
[1]
Prostate Cancer: To Treat or Not to Treat? [J].
Abrahamsson, Per-Anders .
EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (05) :418-423
[2]
Watchful waiting and active surveillance: the current position [J].
Adolfsson, Jan .
BJU INTERNATIONAL, 2008, 102 (01) :10-14
[3]
How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium [J].
Altwein, J ;
Ekman, P ;
Barry, M ;
Biermann, C ;
Carlsson, P ;
Fossa, S ;
Kiebert, G ;
Kuchler, T ;
McLeod, D ;
Porter, A ;
Steineck, G .
UROLOGY, 1997, 49 (4A) :66-76
[4]
Watchful waiting and health related quality of life for patients with localized prostate cancer: Data from CaPSURE [J].
Arredondo, SA ;
Downs, TM ;
Lubeck, DP ;
Pasta, DJ ;
Silva, SJ ;
Wallace, KL ;
Carroll, PR .
JOURNAL OF UROLOGY, 2004, 172 (05) :1830-1834
[5]
What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance?: An analysis of the CaPSURE™ database [J].
Barocas, Daniel A. ;
Cowan, Janet E. ;
Smith, Joseph A. ;
Carroll, Peter R. .
JOURNAL OF UROLOGY, 2008, 180 (04) :1330-1334
[6]
Radical prostatectomy versus watchful waiting in early prostate cancer [J].
Bill-Axelson, A ;
Holmberg, L ;
Ruutu, M ;
Häggman, M ;
Andersson, SO ;
Bratell, S ;
Spångberg, A ;
Busch, C ;
Nordling, S ;
Garmo, H ;
Palmgren, J ;
Adami, HO ;
Norlén, BJ ;
Johansson, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (19) :1977-1984
[7]
Is 'watchful waiting' a real choice for men with prostate cancer? A qualitative study [J].
Chapple, A ;
Ziebland, S ;
Herxheimer, A ;
Mcpherson, A ;
Shepperd, S ;
Miller, R .
BJU INTERNATIONAL, 2002, 90 (03) :257-264
[8]
Feasibility study: Watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression [J].
Choo, R ;
Klotz, L ;
Danjoux, C ;
Morton, GC ;
DeBoer, G ;
Szumacher, E ;
Fleshner, N ;
Bunting, P ;
Hruby, G .
JOURNAL OF UROLOGY, 2002, 167 (04) :1664-1669
[9]
The changing face of low-risk prostate cancer: Trends in clinical presentation and primary management [J].
Cooperberg, MR ;
Lubeck, DP ;
Meni, MV ;
Mehta, SS ;
Carroll, PR .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2141-2149
[10]
Davison B Joyce, 2007, Cancer Nurs, V30, pE7